EMA Authorised: Yeytuo (lenacapavir sodium) — Gilead Sciences Ireland Unlimited Company

View source ↗

Summary

EMA authorised Yeytuo (lenacapavir sodium) from Gilead Sciences Ireland Unlimited Company for HIV infections including HIV-1 infection. This marks the approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Yeytuo (lenacapavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections;HIV-1. MAH: Gilead Sciences Ireland Unlimited Company. Decision date: 19/02/2026